Relative bioavailability of ertugliflozin tablets containing the amorphous form versus tablets containing the cocrystal form
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Clinical Pharmacology and Therapeutics"
DOI: 10.5414/cp204212
Abstract: Objectives: Ertugliflozin is a selective sodium-glucose cotransporter 2 inhibitor approved for the treatment of type 2 diabetes in adults. In its natural form, ertugliflozin exists as an amorphous solid with physicochemical properties that prevent commercial… read more here.
Keywords: tablets containing; bioavailability ertugliflozin; relative bioavailability; form ... See more keywords